Prolonged or too frequent administration of the drug in young children can lead to blockage of the central nervous system, hypothermia, coma, prolonged dilatation of the pupil. Naphazoline can cause a sudden decrease in blood pressure and tachycardia.
There are no data on acute overdose of drops administered topically into the conjunctival sac.
Hypersensitivity.
Drowsiness, dry mouth, dizziness, nausea, headache, weakness, numbness of the mucous membranes, decreased reaction rate.
Drowsiness, dizziness, decreased reaction rate, headache, weakness, dry mouth, numbness of mucous membranes, nausea.
Increased excitability (especially in children).
Allergic diseases, allergodermatoses, gastric ulcer and duodenal ulcer, insomnia, vomiting of pregnant women, Meniere's syndrome, motion sickness, radiation sickness, parkinsonism.
Allergic diseases, allergodermatoses, gastric ulcer and duodenal ulcer, insomnia, vomiting of pregnant women, Meniere's syndrome, motion sickness, radiation sickness, parkinsonism.
Allergic reactions of the upper respiratory tract (runny nose, lacrimation, tickling in the throat or nose).
Diphenhydramine Hydrochloride Pharmaceutical Associates
Diphenhydramine
No information provided.
In / m - 1-5 ml of 1% solution.
Inside - 0.025–0.05 g (children-0.01-0.03 g) 1-3 times a day. Race-10 - 15 days.
Externally. Adults and children over 2 years Diphenhydramine Hydrochloride Pharmaceutical Associates® apply to the affected areas of the skin (a strip of gel 3-5 cm long on the affected area of the size of the palm) 3-4 times a day and distribute with light massaging movements.
In / m - 1-5 ml of 1% solution. Inside, adults - 25-50 mg 1-3 times a day.
Children - 10-30 mg 1-3 times a day. Race-10 - 15 days.
Inside, adults-according to Table 2. every 6 hours, but not more than 12 tables. per day.
Children from 6 to 12 years-according to 1 table. (no more than 6) per day. Children under 6 years of age should consult a doctor.
